The behavior therapies: therapeutic breakthrough or latest fad?
The author critically examines the evidence for the effectiveness of the behavior therapies as described in the American Psychaitric Association's task force report on behavior therapy. He concludes that current attempts to evaluate behavior therapy suffer from inadequate methodology and that the claims for its therapeutic efficacy are excessive and unsupported by the controlled clinical evidence.
D001521:Behavior Therapy / Q000266:history / Q000379:methods / Q000592:standards; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000628:therapy*; D010919:Placebos; D012107:Research Design; D005879:Tourette Syndrome / Q000188:drug therapy / Q000628:therapy
D010919:Placebos; D006220:Haloperidol